Aspergo Labs Publishes Results on First Oral Spray for ED

Aspergo Labs released a Phase 1 Study proving the efficacy of their oral spray for erectile dysfunction, revealing that this new product absorbs within 5 minutes: twice as fast as existing sildenafil tablets. Read the full press release on Exec Edge today.

Read Now
Previous
Previous

Authentrics.AI and Safire selected for Innov865 Pitch Competition

Next
Next

Sparkz wins $15M from CAEATFA